DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Amado RG, Wolf M, Peeters M. et al.
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.
J Clin Oncol 2008; 26: 1626-1634
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.